Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Liabilities and Shareholders Equity (2017 - 2025)

Mesoblast's Liabilities and Shareholders Equity history spans 7 years, with the latest figure at $669.4 million for Q2 2023.

  • For Q2 2023, Liabilities and Shareholders Equity rose 1.1% year-over-year to $669.4 million; the TTM value through Jun 2023 reached $2.8 billion, up 0.62%, while the annual FY2025 figure was $784.7 million, 17.27% up from the prior year.
  • Liabilities and Shareholders Equity for Q2 2023 was $669.4 million at Mesoblast, up from $662.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $744.7 million in Q2 2021 and bottomed at $652.1 million in Q2 2019.
  • The 5-year median for Liabilities and Shareholders Equity is $669.4 million (2023), against an average of $692.4 million.
  • The largest annual shift saw Liabilities and Shareholders Equity increased 12.5% in 2020 before it decreased 11.09% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $652.1 million in 2019, then increased by 12.5% to $733.6 million in 2020, then grew by 1.52% to $744.7 million in 2021, then decreased by 11.09% to $662.1 million in 2022, then rose by 1.1% to $669.4 million in 2023.
  • Per Business Quant, the three most recent readings for MESO's Liabilities and Shareholders Equity are $669.4 million (Q2 2023), $662.1 million (Q2 2022), and $744.7 million (Q2 2021).